{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:48:54Z","timestamp":1785426534750,"version":"3.56.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Botulinum toxin is one of the most potent neurotoxins, but when injected into an overactive muscle, it can transiently alleviate an involuntary movement, such as dystonia. The primary aim of this article is to provide a comprehensive review of the various forms of dystonia observed in patients with Parkinson\u2019s disease who can benefit from a therapeutic trial of botulinum toxin. Although most of these indications are not supported by randomized controlled clinical trials and, therefore, not approved by the Food and Drug Administration, there are many open-label trials supporting a large body of empirical experience testifying to the benefits of botulinum toxin treatment in these conditions.<\/jats:p>","DOI":"10.3389\/fnins.2024.1371601","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T04:33:14Z","timestamp":1712550794000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of botulinum toxin in the management of dystonia in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"18","author":[{"given":"Charenya","family":"Anandan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mdc3.12782","article-title":"Severe jaw\u2010opening dystonia as an unusual manifestation of levodopa\u2010related wearing\u2010off in Parkinson's disease, and successful treatment with botulinum toxin injection","volume":"6","author":"Agarwal","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/mds.29387","article-title":"Isolated cervical dystonia: diagnosis and classification","volume":"38","author":"Albanese","year":"2023","journal-title":"Mov. Disord."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"122810","DOI":"10.1016\/j.jns.2023.122810","article-title":"Botulinum toxin treatment in parkinsonism","volume":"456","author":"Anandan","year":"2023","journal-title":"J. Neurol. Sci."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.parkreldis.2018.11.003","article-title":"Botulinum toxin for Pisa syndrome: an MRI-, ultrasound- and electromyography-guided pilot study","volume":"62","author":"Artusi","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1212\/01.wnl.0000171857.09079.9f","article-title":"Camptocormia","volume":"65","author":"Azher","year":"2005","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/jnnp.62.4.352","article-title":"Dystonia in progressive supranuclear palsy","volume":"62","author":"Barclay","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1002\/mds.21694","article-title":"Botulinum toxin treatment of lateral axial dystonia in parkinsonism","volume":"22","author":"Bonanni","year":"2007","journal-title":"Mov. Disord."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.toxicon.2017.08.018","article-title":"Botulinum toxin in parkinsonism: the when, how, and which for botulinum toxin injections","volume":"147","author":"Cardoso","year":"2018","journal-title":"Toxicon"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.14802\/jmd.12008","article-title":"Levodopa-induced facial dystonia in a case of progressive Supranuclear palsy","volume":"5","author":"Chung","year":"2012","journal-title":"J. Mov. Disord."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/mds.22249","article-title":"Injection of the iliopsoas muscle with botulinum toxin in camptocormia","volume":"24","author":"Colosimo","year":"2009","journal-title":"Mov. Disord."},{"key":"ref9001","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/s0140-6736(72)92694-3","article-title":"Levodopa-induced dystonia","volume":"2","author":"Cooper","year":"1972","journal-title":"The Lancet."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/mds.1186","article-title":"Treatment of dystonic clenched fist with botulinum toxin","volume":"16","author":"Cordivari","year":"2001","journal-title":"Mov. Disord."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF02333858","article-title":"Botulinum a toxin treatment for eyelid spasm, spasmodic torticollis and apraxia of eyelid opening","volume":"11","author":"Defazio","year":"1990","journal-title":"Ital. J. Neurol. Sci."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1002\/mds.22676","article-title":"Goal attainment after treatment of parkinsonian camptocormia with botulinum toxin","volume":"24","author":"Fietzek","year":"2009","journal-title":"Mov. Disord."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/jnnp.57.5.659","article-title":"The use of botulinum toxin to treat \"striatal\" toes","volume":"57","author":"Giladi","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/toxins10120532","article-title":"Spatiotemporal gait analysis and lower limb functioning in foot dystonia treated with botulinum toxin","volume":"10","author":"Gupta","year":"2018","journal-title":"Toxins (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2340\/16501977-2094","article-title":"Botulinum toxin for foot dystonia in patients with Parkinson\u00e2\u20ac\u2122s disease having deep brain stimulation: a case series and a pilot study","volume":"48","author":"Gupta","year":"2016","journal-title":"J. Rehabil. Med."},{"key":"ref9002","article-title":"Botulinum Toxin in the Treatment of Cervical Dystonia: Evidence-Based Review","volume-title":"Dystonia","author":"Hammoud","year":"2022"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/toxins15020081","article-title":"Botulinum toxin treatment of motor disorders in Parkinson disease\u2014a systematic review","volume":"15","author":"Jabbari","year":"2023","journal-title":"Toxins (Basel)"},{"key":"ref9003","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1001\/jama.1970.03170100062021","article-title":"Pyridoxine for levodopa-induced dystonia","volume":"211","author":"Jameson","year":"1970","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/jnnp.60.6.704","article-title":"Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening","volume":"60","author":"Jankovic","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.toxicon.2008.11.013","article-title":"Disease-oriented approach to botulinum toxin use","volume":"54","author":"Jankovic","year":"2009","journal-title":"Toxicon"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2018.12.002","article-title":"Use of botulinum toxin in Parkinson's disease","volume":"59","author":"Jocson","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/toxins13020087","article-title":"Use of botulinum neurotoxin in parkinson's disease: a critical appraisal","author":"Jost","year":"2021","journal-title":"Toxins (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jns.2007.08.013","article-title":"High doses of botulinum toxin effectively treat disabling up-going toe","volume":"264","author":"Kurtis","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"ref9004","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1007\/s00415-022-11280-y","article-title":"Comparison of Botulinum neurotoxin efficiency in dystonia associated with Parkinson\u2019s disease and atypical parkinsonism: a retrospective study with a self-reported improvement scale","volume":"269","author":"Lapostolle","year":"2022","journal-title":"J. Neurol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/mds.870100425","article-title":"Botulinum a toxin for the so\u2010called apraxia of lid opening","volume":"10","author":"Lepore","year":"1995","journal-title":"Mov. Disord."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/mdc3.12411","article-title":"Outcome on balance and gait following botulinum toxin treatment for striatal foot in Parkinson's disease","volume":"4","author":"Lindholm","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1212\/CPJ.0000000000200240","article-title":"Blepharoclonus in parkinsonism","volume":"14","author":"Margolesky","year":"2024","journal-title":"Neurol. Clin. Pract."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"116995","DOI":"10.1016\/j.jns.2020.116995","article-title":"Orofacial dystonia and associated bulbar symptoms in multiple system atrophy: a blinded video analysis","volume":"417","author":"Marsili","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.5334\/tohm.186","article-title":"Comparable botulinum toxin outcomes between primary and secondary Blepharospasm: a retrospective analysis","volume":"4","author":"Martinez-Ramirez","year":"2014","journal-title":"Tremor Other Hyperkinet. Mov. (N.Y.)"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/bs.irn.2023.05.001","article-title":"Dystonia and Parkinson\u2019s disease: do they have a shared biology?","volume":"169","author":"Matar","year":"2023","journal-title":"Int. Rev. Neurobiol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/joor.13496","article-title":"Prevalence of temporomandibular disorders in subjects affected by Parkinson disease: a systematic review and metanalysis","volume":"50","author":"Minervini","year":"2023","journal-title":"J. Oral Rehabil."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jns.2018.03.023","article-title":"Levodopa-induced dystonia in a patient with possible progressive supranuclear palsy with progressive gait freezing","volume":"388","author":"Modreanu","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"107587","DOI":"10.1016\/j.toxicon.2023.107587","article-title":"Evaluation of therapeutic benefits of botulinum toxin for foot dystonia associated with Parkinson\u2019s disease","author":"Ni","year":"2023","journal-title":"Toxicon"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1002\/mdc3.13881","article-title":"Levodopa\u2010induced jaw and facial dystonia in a case of progressive Supranuclear palsy with Blepharospasm","volume":"10","author":"Onder","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e559","DOI":"10.1212\/WNL.0000000000004951","article-title":"Onabotulinum toxin-a injections for sleep bruxism: a double-blind, placebo-controlled study","volume":"90","author":"Ondo","year":"2018","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/mds.870100317","article-title":"\u201cOff\u201d painful dystonia in Parkinson's disease treated with botulinum toxin","volume":"10","author":"Pacchetti","year":"1995","journal-title":"Mov. Disord."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5334\/tohm.285","article-title":"Occurrence of dysphagia following botulinum toxin injection in parkinsonism-related cervical dystonia: a retrospective study","volume":"6","author":"Patterson","year":"2016","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.parkreldis.2015.02.012","article-title":"Levodopa-induced lateral jaw deviation dystonia","volume":"21","author":"Pfeiffer","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0003-9993(97)90169-6","article-title":"Botulinum toxin treatment of apraxia of eyelid opening in progressive supranuclear palsy: report of two cases","volume":"78","author":"Piccione","year":"1997","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.parkreldis.2017.10.009","article-title":"Incobotulinum toxin a in Parkinson's disease with foot dystonia: a\u2009double blind randomized trial","volume":"46","author":"Rieu","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"6929","DOI":"10.1007\/s10072-022-06424-x","article-title":"Diagnostic and therapeutic recommendations in adult dystonia: a joint document by the Italian Society of Neurology, the Italian academy for the study of Parkinson\u2019s disease and movement disorders, and the Italian network on botulinum toxin","volume":"43","author":"Romano","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3109\/00207454.2011.558260","article-title":"The broadening application of Chemodenervation in X-linked dystonia-parkinsonism (part II): an open-label experience with botulinum toxin-a (Dysport\u00ae) injections for Oromandibular, lingual, and truncal-axial Dystonias","volume":"121","author":"Rosales","year":"2011","journal-title":"Int. J. Neurosci."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/01676830.2018.1490443","article-title":"Botulinum toxin-B injection into the lacrimal gland and posterior cricoarytenoid muscle for the treatment of epiphora and abductor spasmodic dysphonia secondary to Parkinson\u2019s disease","volume":"38","author":"Sachdev","year":"2019","journal-title":"Orbit (London)"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00415-009-5310-4","article-title":"Botulinum toxin type a and a rehabilitation program in the treatment of Pisa syndrome in Parkinson\u2019s disease","volume":"257","author":"Santamato","year":"2010","journal-title":"J. Neurol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1212\/WNL.0000000000011922","article-title":"Laryngeal dystonia","volume":"96","author":"Simonyan","year":"2021","journal-title":"Neurology"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0303-8467(02)00128-2","article-title":"Levodopa-induced oromandibular dystonia in progressive supranuclear palsy","volume":"105","author":"Tan","year":"2003","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.parkreldis.2014.07.015","article-title":"Botulinum toxin type a potentiates the effect of neuromotor rehabilitation of Pisa syndrome in Parkinson disease: a placebo controlled study","volume":"20","author":"Tassorelli","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/mdc3.12759","article-title":"Prominent Oromandibular dystonia as levodopa\u2010induced dyskinesia in idiopathic Parkinson's disease","volume":"6","author":"Tee","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s40120-018-0108-x","article-title":"Injection of Onabotulinum toxin a into the bilateral external oblique muscle attenuated Camptocormia: a prospective open-label study in six patients with Parkinson\u2019s disease","volume":"7","author":"Todo","year":"2018","journal-title":"Neurol. Ther."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1468-1331.2006.01443.x","article-title":"Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations","volume":"13","author":"Truong","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/mds.1038","article-title":"Dystonia in corticobasal degeneration","volume":"16","author":"Vanek","year":"2001","journal-title":"Mov. Disord."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e052329","DOI":"10.1136\/bmjopen-2021-052329","article-title":"Parkinson\u2019s disease, temporomandibular disorder pain and bruxism and its clinical consequences: a protocol of a single-Centre observational outpatient study","volume":"12","author":"Verhoeff","year":"2022","journal-title":"BMJ Open"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/mds.21967","article-title":"Ultrasound\u2010guided injection of the iliopsoas muscle with botulinum toxin in camptocormia","volume":"23","author":"von Coelln","year":"2008","journal-title":"Mov. Disord."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00702-019-01986-1","article-title":"Hand, foot, and spine deformities in parkinsonian disorders","volume":"126","author":"Wijemanne","year":"2019","journal-title":"J. Neural Transm."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3988\/jcn.2005.1.2.159","article-title":"Clinical analysis of Blepharospasm and apraxia of eyelid opening in patients with parkinsonism","volume":"1","author":"Yoon","year":"2005","journal-title":"J. Clin. Neurol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1371601\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T04:33:17Z","timestamp":1712550797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1371601\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":58,"alternative-id":["10.3389\/fnins.2024.1371601"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2024.1371601","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"article-number":"1371601"}}